Cepheid's Q2 Revenues Jump 35 Percent; Shares Soar
July 22, 2011
Cepheid's Q2 Revenues Jump 35 Percent; Shares Soar
Strong sales of its clinical systems and consumables pushed the firm's top line up 35 percent, while Cepheid turned in its third consecutive quarter of GAAP profitability.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.